Fintel reports that on July 13, 2023, Goldman Sachs maintained coverage of 10x Genomics Inc - (NASDAQ:TXG) with a Sell recommendation. Analyst Price Forecast Suggests 0.79% Downside As of July 6, 2023 ...
Fintel reports that on September 3, 2024, Leerink Partners initiated coverage of 10x Genomics (NasdaqGS:TXG) with a Outperform recommendation. As of August 26, 2024, the average one-year price target ...
Fintel reports that on May 4, 2023, TD Cowen maintained coverage of 10x Genomics Inc - (NASDAQ:TXG) with a Outperform recommendation. As of April 24, 2023, the average one-year price target for 10x ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback